← back to search

Maria Pia Amato

University of Alabama at Birmingham · US
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Medicine, Multiple sclerosis, Pregnancy, Expanded Disability Status Scale, Neurology, and Disease.
h-index
citations
6,706
works
63
NIH funding
primary concept
email

Recent publications

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
The Lancet Neurology 2025cited by 254position: middledoi
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT
Nature Reviews Neurology 2025cited by 42position: middledoi
Advancing multiple sclerosis management in older adults
Nature Reviews Neurology 2025cited by 19position: middledoi
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion
Journal of Neurology 2025cited by 15position: middledoi
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study
Neurological Sciences 2025cited by 4position: middledoi
De-escalating and discontinuing disease-modifying therapies in multiple sclerosis
Brain 2024cited by 22position: middledoi
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis
Annals of Clinical and Translational Neurology 2024cited by 22position: middledoi
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody‐associated Disease, Aquaporin‐4 Antibody‐Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
Annals of Neurology 2024cited by 15position: middledoi
Priority setting: women’s health topics in multiple sclerosis
Frontiers in Neurology 2024cited by 14position: middledoi
Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trial
Journal of Neurology Neurosurgery & Psychiatry 2024cited by 9position: middledoi
Family planning considerations in people with multiple sclerosis
The Lancet Neurology 2023cited by 119position: middledoi
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial
The Lancet Neurology 2023cited by 60position: middledoi
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
Multiple Sclerosis Journal 2023cited by 54position: middledoi
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
JAMA Neurology 2023cited by 50position: middledoi
Multiple Sclerosis Progression and Relapse Activity in Children
JAMA Neurology 2023cited by 39position: middledoi
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
European Journal of Neurology 2023cited by 16position: middledoi
Multiple sclerosis progression: time for a new mechanism-driven framework
The Lancet Neurology 2022cited by 587position: middledoi
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
Journal of Neurology 2022cited by 179position: middledoi
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Neurology 2022cited by 46position: middledoi
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Multiple Sclerosis Journal 2022cited by 45position: middledoi
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions
Multiple Sclerosis and Related Disorders 2022cited by 40position: middledoi
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults
Brain 2022cited by 37position: middledoi
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis
Journal of Neurology Neurosurgery & Psychiatry 2022cited by 29position: middledoi
Women's Health in Multiple Sclerosis: A Scoping Review
Frontiers in Neurology 2022cited by 24position: middledoi
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis
Journal of Neurology 2022cited by 15position: middledoi
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis
JAMA Neurology 2021cited by 177position: lastdoi
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis
Cell Reports 2021cited by 85position: middledoi
Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis
Neurology 2021cited by 29position: middledoi
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study
Multiple Sclerosis Journal 2021cited by 15position: middledoi
Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)
Multiple Sclerosis Journal - Experimental Translational and Clinical 2021cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Angelo Ghezzi · Università degli Studi del Piemonte Orientale “Amedeo Avogadro”14 papers (2012–2025)Francesco Patti · Université Claude Bernard Lyon 113 papers (2012–2025)Massimo Filippi · McGill University Health Centre11 papers (2017–2025)María Trojano · University of Bari Aldo Moro9 papers (2012–2025)Emilio Portaccio · University of Leicester9 papers (2012–2021)Matilde Inglese · University of Genoa8 papers (2014–2025)Paolo Gallo · University of Padua7 papers (2016–2025)Maria A. Rocca · Vita-Salute San Raffaele University7 papers (2017–2024)Carlo Pozzilli · Cardiff University6 papers (2012–2022)Amber Salter · Southwestern Medical Center6 papers (2020–2024)Mar Tintoré · University of Manitoba6 papers (2014–2024)Peter Feys · KU Leuven5 papers (2020–2024)John DeLuca · Rutgers, The State University of New Jersey5 papers (2020–2024)Ulrik Dalgas · Aarhus University5 papers (2020–2024)Brian M. Sandroff · University of Alabama at Birmingham5 papers (2020–2024) · 5 papers (2016–2021)Eleonora Cocco · Cardiff University5 papers (2013–2025)Jennifer Freeman · University of Sheffield5 papers (2020–2024)Anthony Feinstein · St. Michael's Hospital5 papers (2020–2024)Jeremy Chataway · Queen Mary University of London5 papers (2020–2024)